A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors	non-small cell lung carcinoma	Active, not recruiting	Phase 1	2025-11-24		NCT05117476

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cullinan Therapeutics Inc.	10

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alfred Health	Melbourne	Australia	32
Biokinetica	Józefów	Poland	1
Carolina BioOncology Institute	Huntersville	United States	22
City of Hope	Irvine	United States	9
City of Hope	Duarte	United States	238
Clinica Universidad de Navarra	Pamplona	Spain	36
Dana-Farber Cancer Institute	Boston	United States	626
Florida Cancer Specialists	Sarasota	United States	47
Hackensack Meridian Health	Hackensack	United States	22
Hospital Clinic Barcelona	Barcelona	Spain	37
Hospital Universitari Parc Tauli	Sabadell	Spain	3
Hospital Universitario Insular de Gran canaria	Las Palmas de Gran Canaria	Spain	6
Linear Clinical Research	Nedlands	Australia	23
Med-Polonia Sp. zo. o.	Poznan	Poland	1
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Monash Health	Clayton	Australia	74
Narodowy Insytut Onkologii im Marii Sklodowskiej-Curie	Warsaw	Poland	1
Sarah Cannon Research Institute	Nashville	United States	119
START Barcelona	Barcelona	Spain	4
START Madrid FJD	Madrid	Spain	2
START Midwest	Grand Rapids	United States	79
START San Antonio	San Antonio	United States	30
University of Alabama at Birmingham	Birmingham	United States	193
Virginia Cancer Center	Fairfax	United States	1

Clinical trials